CB three-lens brief
Evidence-based stock research on CB. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Earnings scheduled 2026-07-21.
CB closed at $345.11 (-0.77%) as of 2026-07-10. Market cap: $133.85B. P/E (trailing) 12.2. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.. Last quarter: Revenue $11.72B, net income $2.32B, free cash flow $12.62B. Watching for: 2026-07-21 earnings release (10 days out).
Why three lenses on CB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CBacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CB brief"></iframe>